STM Publishing Group Limited


   STM Publishing Group Pty Ltd


AA Contents

AA Contents

副标题

About the Journal

Aging Advances (AA) is a cutting-edge, peer-reviewed, open access journal committed to advancing the field of aging and geroscience research by disseminating high-quality and innovative studies. The journal is dedicated to providing a platform for scientists, researchers, and clinicians to contribute to the understanding of fundamental issues in the biology and technology of aging, pathophysiology of age-related diseases, and innovative therapies for diseases afflicting the elderly population. The diseases of interest include (but not limited to) cardiovascular disease, stroke, Alzheimer’s disease, vascular cognitive impairment and dementia, cancer, hypertension, type-2 diabetes, chronic obstructive pulmonary disease, and osteoarthritis. Aging Advances welcomes original research articles, reviews, and editorial papers that push the boundaries of knowledge in the multidisciplinary realm of aging and geroscience.


Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris Primo Central, Google Scholar, Hinari, Infotrieve, Netherlands ISSN centre, ProQuest, TDNet, Wanfang Data


We welcome original research articles, reviews, and perspectives/editorials that address critical issues in the following areas:
-The biology of aging and underlying mechanisms that drive age-related changes at the molecular, cellular, and systemic levels.
-Innovations in geroscience technology, including biomarkers, diagnostics, and therapeutic interventions aimed at extending healthy lifespan.
-The pathophysiology and treatment of age-related diseases, including but not limited to cardiovascular disease, stroke, Alzheimer’s disease, vascular cognitive impairment and dementia, cancer, hypertension, type-2 diabetes, chronic obstructive pulmonary disease (COPD), and osteoarthritis.
-Interdisciplinary approaches that integrate insights from genetics, epigenetics, immunology, and pharmacology to advance our understanding of aging processes and interventions.
-Clinical and preclinical studies focused on novel therapeutic strategies and their translational potential to improve health outcomes in the elderly.
-Public health perspectives and policy research that address the challenges and opportunities in managing aging populations and promoting healthy aging.
By fostering a multidisciplinary dialogue, Aging Advances aims to bridge the gap between basic research and clinical application, ultimately contributing to the development of effective strategies to combat age-related diseases and enhance the quality of life for the aging population.


Biology of Aging: AA aims to explore and unravel the biological mechanisms underlying the aging process, with a focus on reporting on mechanistic issues in the field of tissue structure and functional behavior during cellular senescence, and the link between senescence and age-related diseases. Submissions addressing the molecular, cellular, and physiological aspects of aging, as well as investigations into the genetic and environmental factors influencing longevity, are highly encouraged.


Technological Innovations: The journal seeks to showcase advancements in technology that contribute to our understanding of aging or offer innovative solutions for promoting healthy aging. This includes but is not limited to studies on bioinformatics, data analytics, medical technologies, and interventions designed to enhance the quality of life in the elderly population.


Interdisciplinary Perspectives: AA recognizes the complex and multifaceted nature of aging. As such, the journal welcomes interdisciplinary research that bridges gaps between biology, medicine, psychology, sociology, and other related fields to provide a comprehensive understanding of the aging process.


Clinical Implications: The journal is dedicated to publishing research with direct relevance to clinical practice. This includes studies on age-related diseases, diagnostic tools, therapeutic interventions, and strategies for promoting healthy aging across diverse populations.


Aging Advances invites researchers, scholars, and practitioners to contribute their valuable work to further the collective understanding of aging and to ultimately improve the well-being of aging populations worldwide.


Readership: Readership cover the field of evolutionary biology, biophysics, genetics, genomics, proteomics, metabolomics, anatomy, histopoetics, molecular biology, cell biology, biochemistry, endocrinology, immunology, physiology, pharmacology, neuroscience, and psychology, and other related fields from basic and clinical research in the subject of aging research.


Mission and Vision: Establishing a multi-functional academic platform for aging research

-The journal will serve as a professional publishing platform for presenting new discoveries, to exchange new ideas,
-We envision the journal to be a catalyst for fostering new collaborations, both online and offline, through the organization of symposiums and other interactive events.
-Bridge the gap between basic scientific research and practical applications in clinical settings.
-By fostering a collaborative environment, we aspire to expedite the translation of scientific discoveries into tangible benefits for the community at large.

-The journal will be a means to enhance and elevate the influence of experts within the field.


Editor-in-Chief:

Salvador Ventura, PhD
Chair Professor of Biochemistry and Molecular Biology
Universitat Autònoma de Barcelona
Institut de Biotecnologia i Biomedicina
Departament de Bioquímica I Biologia Molecular
Protein Folding and Conformational Diseases Lab
Barcelona. Spain

Personal link

《衰老进展》期刊致力于发表高质量和创新的研究来推动衰老和老年科学研究领域的发展。我们的目标是为科学家、研究人员和临床医生提供一个综合平台,以促进对衰老的基本生物学和技术方面的理解、与年龄相关疾病的病理生理学以及开发影响老年人群疾病治疗的新疗法。


我们欢迎针对以下领域关键问题的原创研究文章、综述和观点/社论。


关注热点:


1、衰老生物学在分子、细胞和系统水平上的变化


(1)细胞衰老;2.基因组/蛋白质组不稳定和衰老;3.端粒损耗和衰老;4.表观遗传改变和衰老;5.蛋白质稳态丧失和衰老;6.自噬功能障碍和衰老;7.慢性炎症和衰老;8.细胞间和细胞内通讯改变和衰老;9.线粒体功能障碍和衰老;10.营养感应失调和衰老;11.干细胞衰竭与衰老;12.菌群失调和衰老。


2、老年科学研究中与衰老相关的技术创新


包括延长健康寿命的生物标志物、诊断和治疗干预。


3、与年龄相关疾病的病理生理学变化、机制及其治疗


包括但不限于心血管疾病、中风、阿尔茨海默病、血管性认知障碍和痴呆症、癌症、高血压、2 型糖尿病、慢性阻塞性肺病 (COPD) 和骨关节炎。


研究方法:


1、 采用跨学科方法,促进多学科对话,认识综合遗传学、表观遗传学、免疫学和药理学的新进展,促进对衰老过程和干预措施的深入了解。


2、 关注临床和临床前研究,侧重于新型治疗策略及其转化潜力,以及如何改善老年人的健康状况。旨在弥合基础研究与临床应用之间的差距,最终有助于制定有效的策略来对抗与年龄相关的疾病并提高老龄人口的生活质量。


关键词:


衰老;老年科学;与年龄相关的疾病;心血管疾病;中风;阿尔茨海默病;血管性认知障碍;痴呆症;癌症;高血压;2 型糖尿病;慢性阻塞性肺病 (COPD);骨关节炎;衰老生物学;健康寿命;衰老技术;衰老机制;转化老年科学。衰老和长寿的新理论;公共数据库和分析工具及软件与衰老研究。


读者群:


读者范围涵盖进化生物学、生物物理学、遗传学、基因组学、蛋白质组学、代谢组学、解剖学、组织学、分子生物学、细胞生物学、生物化学、内分泌学、免疫学、生理学、药理学、神经科学和心理学等领域,以及衰老研究基础和临床研究的其他相关领域。